176 related articles for article (PubMed ID: 23672054)
1. [Pharmacokinetic effect of Sappan Lignum on hydroxysafflor yellow A in Carthami Flos].
Xia L; Chen XM; Peng LR; Wang SX; Wang XW; Zuo Y; Zhang P; Liu QS; Zheng XH
Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(2):269-72. PubMed ID: 23672054
[TBL] [Abstract][Full Text] [Related]
2. Comparative Analysis of the Effects of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B in Safflower Series of Herb Pairs Using Prep-HPLC and a Selective Knock-Out Approach.
Qu C; Wang LY; Jin WT; Tang YP; Jin Y; Shi XQ; Shang LL; Shang EX; Duan JA
Molecules; 2016 Nov; 21(11):. PubMed ID: 27827969
[TBL] [Abstract][Full Text] [Related]
3. [Studies on pharmacokinetics of hydroxysafflor yellow A in Carthamus tinctorius and its compound preparation in rat].
Tang J; Ouyang Z; Feng X; Fang J; Cao X
Zhongguo Zhong Yao Za Zhi; 2011 Aug; 36(16):2246-9. PubMed ID: 22097340
[TBL] [Abstract][Full Text] [Related]
4. [Study on distribution of safflor yellow A in tissues of mice].
Liu YQ; Zhou HT; Bi KS
Yao Xue Xue Bao; 2004 Mar; 39(3):217-9. PubMed ID: 15171659
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and excretion of hydroxysafflor yellow A, a potent neuroprotective agent from safflower, in rats and dogs.
Chu D; Liu W; Huang Z; Liu S; Fu X; Liu K
Planta Med; 2006 Apr; 72(5):418-23. PubMed ID: 16557455
[TBL] [Abstract][Full Text] [Related]
6. Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats.
Wang S; Sun M; Ping Q
Int J Pharm; 2008 Jun; 358(1-2):198-204. PubMed ID: 18417306
[TBL] [Abstract][Full Text] [Related]
7. Hydroxysafflor yellow A (HSYA) from flowers of Carthamus tinctorius L. and its vasodilatation effects on pulmonary artery.
Bai Y; Lu P; Han C; Yu C; Chen M; He F; Yi D; Wu L
Molecules; 2012 Dec; 17(12):14918-27. PubMed ID: 23519263
[TBL] [Abstract][Full Text] [Related]
8. Rapid screening and identification of anticoagulation component from carthami flos by two-dimensional thrombin affinity chromatography combined with HPLC-MS/MS.
Qiao Y; Shi Y; Wu C; Hou X; Pan X; Deng Z; Wang S
J Sep Sci; 2021 Aug; 44(16):3061-3069. PubMed ID: 34110096
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic properties of hydroxysafflor yellow A in healthy Chinese female volunteers.
Yang Z; Yang J; Jia Y; Tian Y; Wen A
J Ethnopharmacol; 2009 Jul; 124(3):635-8. PubMed ID: 19570628
[TBL] [Abstract][Full Text] [Related]
10. A novel oral preparation of hydroxysafflor yellow A base on a chitosan complex: a strategy to enhance the oral bioavailability.
Ma GN; Yu FL; Wang S; Li ZP; Xie XY; Mei XG
AAPS PharmSciTech; 2015 Jun; 16(3):675-82. PubMed ID: 25511808
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic Study on Protocatechuic Aldehyde and Hydroxysafflor Yellow A of Danhong Injection in Rats with Hyperlipidemia.
Zhou J; Li M; Jin W; Li X; Fan H; Zhang Y
Pharmacology; 2018; 102(3-4):154-160. PubMed ID: 30045035
[TBL] [Abstract][Full Text] [Related]
12. Hydroxysafflor yellow A attenuates left ventricular remodeling after pressure overload-induced cardiac hypertrophy in rats.
Wang J; Zhang Q; Mei X; Zhang X
Pharm Biol; 2014 Jan; 52(1):31-5. PubMed ID: 24033225
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of hydroxysafflor yellow A and ferulic acid in rat plasma after oral administration of the co-extractum of Rhizoma chuanxiong and Flos Carthami by HPLC-diode array detector.
Qi J; Jin X; Huang L; Ping Q
Biomed Chromatogr; 2007 Aug; 21(8):816-22. PubMed ID: 17441216
[TBL] [Abstract][Full Text] [Related]
14. Determination of hydroxysafflor yellow A in rat plasma and tissues by high-performance liquid chromatography after oral administration of safflower extract or safflor yellow.
Li Y; Zhang ZY; Zhang JL
Biomed Chromatogr; 2007 Mar; 21(3):326-34. PubMed ID: 17221936
[TBL] [Abstract][Full Text] [Related]
15. An LC/MS/MS method for simultaneous quantitation of two homoisoflavones: protosappanin B and brazilin with hypoglycemic activity in rat plasma and its application to a comparative pharmacokinetic study in normal and streptozotocin-treated rats.
Tong XZ; Zhu H; Shi Y; Xu HT; Wang B; Zhao JH
J Ethnopharmacol; 2013 Jul; 148(2):682-90. PubMed ID: 23707335
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic comparisons of hydroxysafflower yellow A in normal and blood stasis syndrome rats.
Tian Y; Yang ZF; Li Y; Qiao Y; Yang J; Jia YY; Wen AD
J Ethnopharmacol; 2010 May; 129(1):1-4. PubMed ID: 20206677
[TBL] [Abstract][Full Text] [Related]
17. UFLC-Q-TOF/MS based screening and identification of the metabolites in plasma, bile, urine and feces of normal and blood stasis rats after oral administration of hydroxysafflor yellow A.
Jin Y; Wu L; Tang Y; Cao Y; Li S; Shen J; Yue S; Qu C; Shan C; Cui X; Zhang L; Duan JA
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1012-1013():124-9. PubMed ID: 26827279
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies.
Zhu H; Wang Z; Ma C; Tian J; Fu F; Li C; Guo D; Roeder E; Liu K
Planta Med; 2003 May; 69(5):429-33. PubMed ID: 12802724
[TBL] [Abstract][Full Text] [Related]
19. Taoren-Honghua herb pair and its main components promoting blood circulation through influencing on hemorheology, plasma coagulation and platelet aggregation.
Liu L; Duan JA; Tang Y; Guo J; Yang N; Ma H; Shi X
J Ethnopharmacol; 2012 Jan; 139(2):381-7. PubMed ID: 22123200
[TBL] [Abstract][Full Text] [Related]
20. Hydroxysafflor yellow A inhibits rat brain mitochondrial permeability transition pores by a free radical scavenging action.
Tian J; Li G; Liu Z; Fu F
Pharmacology; 2008; 82(2):121-6. PubMed ID: 18583922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
